| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |